Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gallbladder01:17

Gallbladder

786
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
786
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

881
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
881

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab with Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancer.

Cancers·2026
Same author

Neuroendocrine Carcinoma of the Gallbladder: Clinicopathologic and Immunohistochemical Analysis of 31 Cases.

The American journal of surgical pathology·2026
Same author

Landscape of clinical trials and impact of precision medicine in biliary tract cancers in the last 45 years: a systematic review and meta-analysis of biomarker-driven trials.

Translational gastroenterology and hepatology·2026
Same author

Molecularly Guided Therapy in Hepatobiliary Cancers: Current Standards and Emerging Horizons.

Hematology/oncology clinics of North America·2026
Same author

The Chile BiLS case-control study of gallbladder cancer.

Archives of public health = Archives belges de sante publique·2026
Same author

ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response.

JCO precision oncology·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Aug 23, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

392

Gallbladder cancer.

Juan C Roa1, Patricia García2, Vinay K Kapoor3

  • 1Department of Pathology, Millennium Institute on Immunology and Immunotherapy, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. croa@uc.cl.

Nature Reviews. Disease Primers
|October 27, 2022
PubMed
Summary
This summary is machine-generated.

Gallbladder cancer (GBC) is a deadly biliary tract cancer. Early detection and novel therapies are crucial for improving outcomes in this challenging disease.

More Related Videos

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

5.9K
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.3K

Related Experiment Videos

Last Updated: Aug 23, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

392
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

5.9K
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.3K

Area of Science:

  • Oncology
  • Gastroenterology
  • Pathogenesis of Gallbladder Cancer

Background:

  • Gallbladder cancer (GBC) presents a poor prognosis due to late diagnosis and limited treatment options.
  • Chronic inflammation, regardless of gallstones, is a key driver of GBC development.
  • Current treatments are insufficient, highlighting the need for better diagnostic and therapeutic strategies.

Purpose of the Study:

  • To review recent advances in understanding GBC pathogenesis.
  • To highlight unmet clinical needs in GBC management, including biomarker discovery and early detection.
  • To discuss the evolving treatment landscape for GBC.

Main Methods:

  • Review of omics technologies for GBC pathogenesis.
  • Analysis of advancements in surgical specimen processing and nomenclature standardization.
  • Evaluation of new systemic therapies, including chemotherapy and immunotherapy.

Main Results:

  • Omics technologies reveal inflammation-driven mechanisms in GBC initiation and progression.
  • Standardized nomenclature and processing improve research data reproducibility.
  • Novel therapies and multidisciplinary care are beginning to alter GBC treatment paradigms.

Conclusions:

  • Improving GBC management requires validated biomarkers for screening and therapy selection.
  • Standardized research practices facilitate early detection and drug discovery.
  • Advances in systemic therapies offer new hope for this recalcitrant cancer.